Abstract
The targeted delivery of drugs is vital in breast cancer treatment due to its
ability to produce long-lasting therapeutic effects with minimal side effects.
This study reports the successful development of doxorubicin hydrochloride
(DOX)-loaded colloidal gold nanoparticles stabilized with acacia gum (AG).
Optimization studies varied AG concentrations (0.25% to 3% w/v) to determine
optimal conditions for nanoparticle synthesis. The resulting acacia stabilized
gold nanoparticles (AGNPs) were characterized using various techniques including
high-resolution transmission electron microscopy (HR-TEM), powder X-ray
diffraction (PXRD), differential scanning calorimetry (DSC), ultraviolet-visible
spectroscopy, Fourier-transform infrared spectroscopy (FT-IR), field emission
scanning electron microscopy (FE-SEM), and selected area electron diffraction
(SAED). In vitro drug release studies demonstrated a higher release rate of DOX
in sodium acetate buffer (pH 5.0) compared to phosphate buffer saline (pH 7.4),
suggesting an enhanced therapeutic efficacy in acidic tumor environments.
Cytotoxicity of DOX-AGNPs and free DOX was assessed in human breast cancer cells
(MDA-MB-231). The DOX-AGNPs exhibited significantly greater cytotoxicity,
indicating enhanced efficacy in targeting cancer cells. This enhancement
suggests that adsorbing DOX on the surface of gold nanoparticles can improve
drug delivery and effectiveness, potentially reducing side effects compared to
pure DOX and traditional delivery methods. Stability tests conducted over six
months at 25±1°C showed significant changes in particle size and PDI, suggesting
limited stability under these conditions. Overall, the acacia-stabilized gold
nanoparticles synthesized in this study exhibit promising characteristics for
drug delivery applications, particularly in cancer therapy, with effective drug
loading, controlled release, and favorable physicochemical properties.
Keywords
green synthesis - gold nanoparticles - breast cancer - acacia gum - doxorubicin hydrochloride